Lotus Pharmaceutical Co., Ltd. (TPE:1795)
Taiwan · Delayed Price · Currency is TWD 354.50
-6.50 (-1.80%)
Feb 2, 2026, 1:35 PM CST
Lotus Pharmaceutical Market Cap
Lotus Pharmaceutical has a market cap or net worth of 94.94 billion as of February 2, 2026. Its market cap has increased by 31.51% in one year.
Market Cap
94.94B
Enterprise Value
101.68B
Revenue
18.66B
Ranking
n/a
PE Ratio
20.01
Stock Price
354.50
Market Cap Chart
Since August 12, 2014, Lotus Pharmaceutical's market cap has increased from 9.19B to 94.94B, an increase of 933.32%. That is a compound annual growth rate of 22.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 2, 2026 | 93.23B | 25.27% |
| Dec 31, 2025 | 74.42B | 4.05% |
| Dec 31, 2024 | 71.52B | -0.57% |
| Dec 29, 2023 | 71.94B | 11.59% |
| Dec 30, 2022 | 64.46B | 152.11% |
| Dec 30, 2021 | 25.57B | 30.27% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PharmaEssentia | 284.78B |
| Bora Pharmaceuticals Co., LTD. | 74.79B |
| Center Laboratories | 30.09B |
| TTY Biopharm Company | 21.21B |
| ScinoPharm Taiwan | 19.49B |
| Alar Pharmaceuticals | 18.00B |
| Grape King Bio | 17.92B |
| Synmosa Biopharma | 16.25B |